Integration of the drug discovery support businesses through the merger of 新薬リサーチセンター and 安評センター
First written in FY2024-Q3. 1 of 3 entries say "Restated". Latest entry: FY2025-H1.
No other company in this theme has enough history to compare yet.
- FY2025-H1AchievedAnnual report
「We had been preparing to integrate the management of the core companies, 新薬リサーチセンター and 安評センター, with the aim of further streamlining operations and strengthening competitiveness and sales capabilities through the consolidation of management resources. The companies merged as scheduled on 1 October 2024.」
The management integration through the merger of 新薬リサーチセンター and 安評センター, scheduled for 1 October 2024, was carried out as planned. - FY2024RestatedAnnual report
「In November 2023, the Company resolved to integrate the management of 新薬リサーチセンター and 安評センター through a merger scheduled for 1 October 2024, with the aim of further streamlining business operations by consolidating management resources, strengthening sales capabilities and establishing a core company with strong competitiveness as the final stage of the group restructuring.」
The annual report reconfirms the plan to merge 新薬リサーチセンター and 安評センター on 1 October 2024, with the objectives of consolidating management resources, streamlining operations and strengthening sales capabilities. It does not state that the merger has been completed. - FY2024-Q3First statedAnnual report
「In November 2023, the Company resolved to integrate the management of 新薬リサーチセンター and 安評センター through a merger scheduled for 1 October 2024, with the aim of further streamlining business operations by consolidating management resources, strengthening sales capabilities and establishing a core company with strong competitiveness as the final stage of the group restructuring.」
A resolution was adopted for an absorption-type merger, with 新薬リサーチセンター as the surviving company and 安評センター as the absorbed company, scheduled for 1 October 2024. The companies aim to integrate their technologies and businesses, consolidate management resources, streamline operations, strengthen sales capabilities and provide seamless end-to-end services.